We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-11.00 | -0.67% | 1,629.00 | 1,629.00 | 1,629.50 | 1,641.00 | 1,611.00 | 1,633.00 | 6,977,520 | 16:29:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.61 | 67.07B |
Date | Subject | Author | Discuss |
---|---|---|---|
28/8/2015 09:38 | And then possibly 40p off the sp | badtime | |
28/8/2015 09:36 | Next divi will be around 40p also. | deanowls | |
28/8/2015 09:33 | C'est la vie | badtime | |
28/8/2015 09:17 | Well said TM. You're a "glass half full" person like me :-)))) NR | nik rosa | |
28/8/2015 08:08 | I said never because with a dividend of 6.5% and a price of 1250p, GSK has to be a gift*...... ;0) * As Pfizer et al will soon demonstrate... *Notwithstanding a massive pipeline of late stage APIs | tradermichael | |
27/8/2015 23:12 | Well never say never | rickyvader | |
27/8/2015 20:34 | Crazy move .... keep forever and earn the dividends. You'll never lose on the capital 'invested' .... ;0) | tradermichael | |
27/8/2015 20:13 | Might let the ones i bought at 1251 go | badtime | |
27/8/2015 12:47 | Watch out for pfizer ! | pugdog | |
27/8/2015 08:56 | Interesting to see if it holds | supermarky | |
27/8/2015 08:07 | Glad I topped up yesterday at 1287.Think we could have bottomed hopefully ? | garycook | |
27/8/2015 07:48 | Noticed the ADR price, huge pop at the open for the UKX on the way. | essentialinvestor | |
26/8/2015 23:47 | Equiv. £13.08 close on WS, after being in the heavy red most of the day. | cyberian | |
26/8/2015 23:47 | Equiv. £13.08 close on WS, after being in the heavy red most of the day. | cyberian | |
26/8/2015 20:33 | I think if it continually hit 1300 and bounced off it then i would be concerned but that hasn't happened yet...so its wait and see on my part | badtime | |
26/8/2015 20:14 | May have a nice bounce tomorrow unless China sells off hard yet again overnight. | essentialinvestor | |
26/8/2015 16:08 | Ei I understand gsk defensive properties and would be bullish if the share price bounced off support. On Tuesdays rally gsk was a sluggish performer and given its under 1300 I was expecting more. Imo there seems no appetite to stay in range and therefore I'm concerned this will fall. Just my opinion | supermarky | |
26/8/2015 16:08 | Supermarkey is that because half the major support is on holiday! | rsharman | |
26/8/2015 14:55 | Mark unfortunately I don't have your TA skills, so just attempt to buy when something looks reasonable, if markets plunge then it tends to take the good bad and ugly with it, without discriminating. There once was a time(might be before your time) when Glaxo significantly outperformed on risk off days. With HFT and internationalisation that no longer tends to happen. Have traded RDSB twice already today and DGE once. | essentialinvestor | |
26/8/2015 14:45 | Yes but major support seems to have gone. This is worrying. It's struggling like mad to keep to 1300 but keeps slipping back. I'm without position but tempted to go short here. Just saying what I see | supermarky | |
26/8/2015 10:27 | cyberian, mentioned the same point previously so agree. Witty will be validated on a volume strategy, rather than paying huge amounts for very specialist treatment areas, watch some of the froth being blown off biotech on any sustained market correction. | essentialinvestor | |
26/8/2015 10:23 | The shift in strategy by Witty and the GSK Board may well prove a smart move earlier than forecast, with cost cutting and a strong pipeline. There is one key medical product review due early in September and the R&D open day in November is eagerly awaited by analysts. | cyberian | |
26/8/2015 10:22 | In this market about everything looks negative Mark. | essentialinvestor | |
26/8/2015 10:13 | Do not think it will go as Low as 1250 again, but who knows in these Crazy Markets. But looking with a long term view, looks cheap and could go to 1650 when the FTSE recovers. Possible recovery 17% on the FTSE, which equates to £15 for GSK. Agree with EI,and a must in any Portfolio with a 6.25% Dividend yield at present | garycook |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions